Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Distribution Mainly distributed in subcutaneous adipose tissue, with a small amount entering the bloodstream
Compound Overview 5-Amino-1MQ is a synthetic research compound studied in biochemical research for its interaction with metabolic pathways and enzyme-related regulatory systems
This product is intended strictly for laboratory research purposes only
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
US$ 22.75
US$ 23.28
US$ 21.04
US$ 28.91
US$ 21.01
US$ 24.06
US$ 22.83
US$ 24.68
US$ 27.11
US$ 22.52
US$ 21.33
US$ 25.39
US$ 23.22
US$ 21.39
US$ 27.80
US$ 28.12
US$ 29.17